Search Result

Results for "

CD70

" in MedChemExpress (MCE) Product Catalog:

By Targets:	ADC Antibody (2) ADC Payload (1) Antibody-Drug Conjugates (ADCs) (2) Drug Intermediate (1) Drug-Linker Conjugates for ADC (1) Fc Receptor (FcR) (1) Microtubule/Tubulin (1) mRNA (1) NF-κB (1) Small Interfering RNA (siRNA) (3) TNF Receptor (5) Topoisomerase (1) Transmembrane Glycoprotein (5)
By Research Areas:	Cancer (13) Inflammation/Immunology (5)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) mRNA (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (3)

Inhibitors & Agonists

Inhibitory Antibodies

Recombinant Proteins

Antibodies

Oligonucleotides

Targets Recommended: CD1 CD38 CD28 CD19 CD20 CD22 Transferrin Receptor CD3 P-selectin CD6 CD2 CD276/B7-H3 CD73 c-Kit LAG-3 L-Selectin CTLA-4 CD47 ALCAM/CD166 Neprilysin E-Selectin Scavenger Receptor Class B type I (SR-BI） FLT3 Tim3 CD44 Anaplastic lymphoma kinase (ALK) CD74 Human leukocyte immunoglobulin (Ig)-like receptors (LILR) P-glycoprotein

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P99014

Cusatuzumab 1 Publications Verification ARGX-110	Fc Receptor (FcR) NF-κB	Inflammation/Immunology Cancer
Cusatuzumab (ARGX-110) is a selective competitive blocker targeting *CD70* (with an equilibrium dissociation constant of 17 pM for binding to human CD70). Cusatuzumab also possesses enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) activity. It is a humanized IgG1 monoclonal antibody, artificially synthesized through humanization and genetic engineering modifications (CH2 region mutation to enhance effector function). Cusatuzumab has a dual mechanism of action: firstly, it competitively blocks the interaction between *CD70* and CD27, inhibiting the CD27-NF-κB signaling pathway, reducing regulatory T cell (Treg) activation and tumor cell proliferation; secondly, by enhancing binding to FcγRIIIa, it mediates ADCC and antibody-dependent cellular phagocytosis (ADCP), directly lysing CD70-positive tumor cells. Cusatuzumab can efficiently eliminate leukemia stem cells (LSCs), induce tumor cell differentiation and apoptosis, restore immune surveillance, and target CD70-positive tumors. Cusatuzumab is used in the study of acute myeloid leukemia (AML) .

HY-P99273

Vorsetuzumab	TNF Receptor	Cancer
Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is a human anti-CD70 antibody. Vorsetuzumab enhances macrophage-related phagocytosis of renal carcinoma cells, shows inhibitory efficacy against Burkitt’s lymphoma .

HY-P99334

Vorsetuzumab mafodotin Anti-Human CD70 Recombinant Antibody; SGN-75	Antibody-Drug Conjugates (ADCs) Microtubule/Tubulin	Cancer
Vorsetuzumab mafodotin (SGN-75) is an Auristatin-based anti-CD70 antibody-drug conjugate (ADC). Vorsetuzumab mafodotin consists of a humanized monoclonal antibody, Vorsetuzumab and an ADC cytotoxin MMAF. Vorsetuzumab mafodotin has antineoplastic activity .

HY-P990264

*Anti-Mouse CD70* Antibody (FR70)**	Transmembrane Glycoprotein	Inflammation/Immunology
Anti-Mouse CD70 Antibody (FR70) is a rat-derived ant-mouse *CD70* IgG2b κ type antibody inhibitor. Anti-Mouse CD70 Antibody (FR70) decreases CD4 ⁺, CD8 ⁺ T cells and eosinophils. Anti-Mouse CD70 Antibody (FR70) shows potent anti-inflammatory and anti-immune effects on allergic lung inflammation and cardiac transplant mice models .

HY-174736

*Human CD70* mRNA**	mRNA	Inflammation/Immunology
Human CD70 mRNA encodes the human CD70 molecule (CD70) protein, a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. CD70 induces proliferation of costimulated T cells, enhances the generation of cytolytic T cells, and contributes to T cell activation. It is also reported to play a role in regulating B-cell activation, cytotoxic function of natural killer cells, and immunoglobulin sythesis.

HY-P991645

MDX-1115 MDX-1203 antibody; BMS-936561 antibody	TNF Receptor ADC Antibody	Cancer
MDX-1115 is a humanized IgG1 monoclonal antibody targeting *CD70. MDX-1115 can be used for synthesis of ADC* BMS-936561 .

HY-178257

Fmoc-Val-Lys-PAB-Exatecan	ADC Payload	Cancer
Fmoc-Val-Lys-PAB-Exatecan is a derivative of Exatecan (DX-8951) (HY-13631). Fmoc-Val-Lys-PAB-Exatecan can be connected to monoclonal antibodies via linkers to form antibody-drug conjugate (ADC) molecules. Fmoc-Val-Lys-PAB-Exatecan is often combined with CD70 mAb to form ADC drugs for the study of tumors with high CD70 expression .

HY-RS02264

CD70 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
CD70 Human Pre-designed siRNA Set A contains three designed siRNAs for CD70 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CD70 Human Pre-designed siRNA Set A CD70 Human Pre-designed siRNA Set A

HY-RS16751

Cd70 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Cd70 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cd70 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cd70 Mouse Pre-designed siRNA Set A Cd70 Mouse Pre-designed siRNA Set A

HY-RS23190

Cd70 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Cd70 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cd70 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cd70 Rat Pre-designed siRNA Set A Cd70 Rat Pre-designed siRNA Set A

HY-160649

MC-Gly-Gly-Phe-Gly-GABA-Exatecan	Drug-Linker Conjugates for ADC Topoisomerase	Cancer
MC-Gly-Gly-Phe-Gly-GABA-Exatecan is an agent linker conjugate for ADC, with an inhibitor for Topoisomerase Exatecan (HY-13631) with IC₅₀ of 22 μM. MC-Gly-Gly-Phe-Gly-GABA-Exatecan targets various antibodies, exhibits cytotoxic and antitumor efficacy in vitro and in vivo .

HY-P991809

*Anti-Mouse CD70* Antibody (TAN 1-7)**	TNF Receptor	Inflammation/Immunology
Anti-Mouse CD70 Antibody (TAN 1-7) reacts with the mouse CD70. Anti-Mouse CD70 Antibody (TAN 1-7) is a non-depleting antibody which blocks the CD70-CD27 interaction. Recommend Isotype Controls: Rat IgG2a kappa, Isotype Control (HY-P990679).

HY-P991562

MDX-1411	Transmembrane Glycoprotein	Cancer
MDX-1411 is a fully human monoclonal antibody targeting *CD70*. MDX-1411 is capable of inducing antibody-dependent cellular cytotoxicity (ADCC). MDX-1411 can be used in the research of B-cell malignancies .

HY-P991120

Balertatug PF-08046040; SGN-CD70	TNF Receptor	Cancer
Balertatug is a human IgG1K antibody targeting *CD70*. The corresponding isotype control is: Human lgG1 kappa, lsotype Control (HY-P99001) .

HY-P990261

Anti-Mouse CD83 Antibody (Michel-17)	Transmembrane Glycoprotein	Inflammation/Immunology Cancer
Anti-Mouse CD83 Antibody (Michel-17) is a rat-derived IgG1 κ type antibody inhibitor, targeting to mouse CD83. Anti-Mouse CD83 Antibody (Michel-17) can block CD83 and inhibit T cells proliferation. Anti-Mouse CD83 Antibody (Michel-17) can be used for the researches of cancer and immunology, such as solid tumor .

HY-178271

P-SCN-Bn-NOTA	Drug Intermediate	Cancer
P-SCN-Bn-NOTA is a metal chelator and molecular imaging probe precursor that allows radiolabeling with Ga-68. P-SCN-Bn-NOTA can be conjugated to CD70-specific molecules B3, B6, ABDB3 and ABDB6 to form NOTA-labeled derivatives. P-SCN-Bn-NOTA is applicable for preclinical PET/CT imaging of *CD70*-expressing tumors in NCG mouse PDX models. P-SCN-Bn-NOTA can be used in studies related to *CD70*-positive tumors .

HY-185484

MDX-1203 BMS-936561	Antibody-Drug Conjugates (ADCs) Transmembrane Glycoprotein	Cancer
MDX-1203 (BMS-936561) is an antibody-drug conjugate targeting *CD70. MDX-1203 binds to CD70* and mediates the specific delivery of its conjugated cytotoxic payload to tumors. MDX-1203 delivers a DNA alkylating payload into cells. MDX-1203 can be used in research related to advanced clear cell renal cell carcinoma and relapsed/refractory B-cell non-Hodgkin lymphoma .

HY-P99014A

Cusatuzumab (FUT8-KO)	Transmembrane Glycoprotein	Cancer
Cusatuzumab (FUT8-KO) is an anti-CD70 monoclonal antibody that prepared by knocking out the fucosyltransferase 8 gene (FUT8) to remove fucose and thereby enhance the ADCC activity of the antibody .

HY-P991930

ARX305 Antibody	ADC Antibody TNF Receptor	Cancer
ARX305 Antibody is an anti-human *CD70* antibody. ARX305 Antibody can generate antibody drug conjugate (ADC) (ARX305) with a potent microtubule inhibitor PEG4-aminooxy-MMAF (AS269) (HY-128968). ARX305 Antibody can be used for the study of multiple solid and hematological cancers .

Cat. No.	Product Name	Target	Research Area	Image

HY-P99014

Cusatuzumab 1 Publications Verification ARGX-110	Fc Receptor (FcR) NF-κB	Inflammation/Immunology Cancer
Cusatuzumab (ARGX-110) is a selective competitive blocker targeting *CD70* (with an equilibrium dissociation constant of 17 pM for binding to human CD70). Cusatuzumab also possesses enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) activity. It is a humanized IgG1 monoclonal antibody, artificially synthesized through humanization and genetic engineering modifications (CH2 region mutation to enhance effector function). Cusatuzumab has a dual mechanism of action: firstly, it competitively blocks the interaction between *CD70* and CD27, inhibiting the CD27-NF-κB signaling pathway, reducing regulatory T cell (Treg) activation and tumor cell proliferation; secondly, by enhancing binding to FcγRIIIa, it mediates ADCC and antibody-dependent cellular phagocytosis (ADCP), directly lysing CD70-positive tumor cells. Cusatuzumab can efficiently eliminate leukemia stem cells (LSCs), induce tumor cell differentiation and apoptosis, restore immune surveillance, and target CD70-positive tumors. Cusatuzumab is used in the study of acute myeloid leukemia (AML) .

HY-P99273

Vorsetuzumab	TNF Receptor	Cancer
Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is a human anti-CD70 antibody. Vorsetuzumab enhances macrophage-related phagocytosis of renal carcinoma cells, shows inhibitory efficacy against Burkitt’s lymphoma .

HY-P99334

Vorsetuzumab mafodotin Anti-Human CD70 Recombinant Antibody; SGN-75	Antibody-Drug Conjugates (ADCs) Microtubule/Tubulin	Cancer
Vorsetuzumab mafodotin (SGN-75) is an Auristatin-based anti-CD70 antibody-drug conjugate (ADC). Vorsetuzumab mafodotin consists of a humanized monoclonal antibody, Vorsetuzumab and an ADC cytotoxin MMAF. Vorsetuzumab mafodotin has antineoplastic activity .

HY-P990264

*Anti-Mouse CD70* Antibody (FR70)**	Transmembrane Glycoprotein	Inflammation/Immunology
Anti-Mouse CD70 Antibody (FR70) is a rat-derived ant-mouse *CD70* IgG2b κ type antibody inhibitor. Anti-Mouse CD70 Antibody (FR70) decreases CD4 ⁺, CD8 ⁺ T cells and eosinophils. Anti-Mouse CD70 Antibody (FR70) shows potent anti-inflammatory and anti-immune effects on allergic lung inflammation and cardiac transplant mice models .

HY-P991645

MDX-1115 MDX-1203 antibody; BMS-936561 antibody	TNF Receptor ADC Antibody	Cancer
MDX-1115 is a humanized IgG1 monoclonal antibody targeting *CD70. MDX-1115 can be used for synthesis of ADC* BMS-936561 .

HY-P991809

*Anti-Mouse CD70* Antibody (TAN 1-7)**	TNF Receptor	Inflammation/Immunology
Anti-Mouse CD70 Antibody (TAN 1-7) reacts with the mouse CD70. Anti-Mouse CD70 Antibody (TAN 1-7) is a non-depleting antibody which blocks the CD70-CD27 interaction. Recommend Isotype Controls: Rat IgG2a kappa, Isotype Control (HY-P990679).

HY-P991562

MDX-1411	Transmembrane Glycoprotein	Cancer
MDX-1411 is a fully human monoclonal antibody targeting *CD70*. MDX-1411 is capable of inducing antibody-dependent cellular cytotoxicity (ADCC). MDX-1411 can be used in the research of B-cell malignancies .

HY-P991120

Balertatug PF-08046040; SGN-CD70	TNF Receptor	Cancer
Balertatug is a human IgG1K antibody targeting *CD70*. The corresponding isotype control is: Human lgG1 kappa, lsotype Control (HY-P99001) .

HY-P990261

Anti-Mouse CD83 Antibody (Michel-17)	Transmembrane Glycoprotein	Inflammation/Immunology Cancer
Anti-Mouse CD83 Antibody (Michel-17) is a rat-derived IgG1 κ type antibody inhibitor, targeting to mouse CD83. Anti-Mouse CD83 Antibody (Michel-17) can block CD83 and inhibit T cells proliferation. Anti-Mouse CD83 Antibody (Michel-17) can be used for the researches of cancer and immunology, such as solid tumor .

HY-P99014A

Cusatuzumab (FUT8-KO)	Transmembrane Glycoprotein	Cancer
Cusatuzumab (FUT8-KO) is an anti-CD70 monoclonal antibody that prepared by knocking out the fucosyltransferase 8 gene (FUT8) to remove fucose and thereby enhance the ADCC activity of the antibody .

HY-P991930

ARX305 Antibody	ADC Antibody TNF Receptor	Cancer
ARX305 Antibody is an anti-human *CD70* antibody. ARX305 Antibody can generate antibody drug conjugate (ADC) (ARX305) with a potent microtubule inhibitor PEG4-aminooxy-MMAF (AS269) (HY-128968). ARX305 Antibody can be used for the study of multiple solid and hematological cancers .

Species:	Human (9) Rat (2) Mouse (3) Cynomolgus (1)
Tag:	His (10) Avi (2) Flag (2) Fc (5)
Source:	HEK293 (13) E. coli (2)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P704279

	CD70 Protein, Human (HEK293, mFc) CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Human	HEK293
	As a ligand of CD27, CD70 protein is an indispensable part of T cell immune coordination and is of particular importance in antiviral responses. The CD70-CD27 pathway emerged as a key player that contributes to the generation and maintenance of T cell-mediated immune responses. CD70 Protein, Human (HEK293, mFc) is the recombinant human-derived CD70 protein, expressed by HEK293, with C-mFc labeled tag.

HY-P704364

	CD70 Protein, Human (HEK293, His-Flag) CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Human	HEK293
	As a ligand of CD27, CD70 protein is an indispensable part of T cell immune coordination and is of particular importance in antiviral responses. The CD70-CD27 pathway emerged as a key player that contributes to the generation and maintenance of T cell-mediated immune responses. CD70 Protein, Human (HEK293, His-Flag) is the recombinant human-derived CD70 protein, expressed by HEK293, with N-His and N-Flag labeled tag.

HY-P72741

	CD70 Protein, Mouse (HEK293, His) CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Mouse	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in mouse contains TNF_2 domain and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Protein, Mouse (HEK293, Fc) is expressed in the HEK293 cells with N terminal 10*His-tag.

HY-P72928

	CD70 Protein, Mouse (HEK293, mFc) CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Mouse	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in mouse contains TNF_2 domain (60-190 a.a) and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Protein, Mouse (HEK293, mFc) is 149 amino acids in length (Q47-P195) and is expressed in the HEK293 cells with N terminal mFc-tag.

HY-P72929

	CD70 Protein, Rat (HEK293, Fc) CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Rat	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in rat contains TNF_2 domain (57-188 a.a) and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Protein, Rat (HEK293, Fc) is 150 amino acids in length (Q46-P195) and is expressed in the HEK293 cells with N terminal hFc-tag.

HY-P72930

	CD70 Protein, Rat (HEK293, His) CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Rat	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in rat contains TNF_2 domain (57-188 a.a) and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Protein, Rat (HEK293, His) is 150 amino acids in length (Q46-P195) and is expressed in the HEK293 cells with N terminal His-tag.

HY-P700035AF

	*Animal-Free CD70* Protein, Human (His)** CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Human	E. coli
	As a ligand of CD27, CD70 protein is an indispensable part of T cell immune coordination and is of particular importance in antiviral responses. The CD70-CD27 pathway emerged as a key player that contributes to the generation and maintenance of T cell-mediated immune responses. Animal-Free CD70 Protein, Human (His) is the recombinant human-derived animal-FreeCD70 protein, expressed by E. coli , with N-His labeled tag. This product is for cell culture use only.

HY-P72740

	CD70 Protein, Human (HEK293, Fc) CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Human	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in human contains transmembrane domain and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Protein, Human (HEK293, Fc) is 149 amino acids in length (Q45-P193) and is expressed in the HEK293 cells with C terminal hFc-tag.

HY-P75387

	CD70 Protein, Human (Biotinylated, HEK293, Fc-Avi) CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Human	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in human contains transmembrane domain and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Protein, Human (Biotinylated, HEK293, Fc-Avi) is 155 amino acids in length (Q39-P193) and is expressed in the HEK293 cells with N terminal hFc- and Avi-tag.

HY-P77620

	CD70 Protein, Cynomolgus (HEK293, His) CD70 molecule; CD70; TNFSF7; CD27 Ligand; CD27-L; CD27LG; Ki-24 antigen; TNFSF7G	Cynomolgus	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in cynomolgus contains TNF_2 domain (57-189 a.a) and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Protein, Cynomolgus (HEK293, His) is 156 amino acids in length (Q39-P194) and is expressed in the HEK293 cells with a N terminal His-tag.

HY-P78103

	CD70 Trimer Protein, Human (Biotinylated, HEK293, His) CD70 molecule; CD70; TNFSF7; CD27 Ligand; CD27-L; CD27LG; Ki-24 antigen; TNFSF7G	Human	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in human contains transmembrane domain and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Trimer Protein, Human (Biotinylated, HEK293, His) is a biotinylated CD70 protein trimeric complex, is expressed in the HEK293 cells, with a N terminal His-tag.

HY-P78540

	*FITC-Labeled CD70* Protein, Human (HEK293, His)** CD70 molecule; CD70; TNFSF7; CD27 Ligand; CD27-L; CD27LG; Ki-24 antigen; TNFSF7G	Human	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in human contains transmembrane domain and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Protein, Human (FITC, HEK293, His) is a luorescein isothiocyanate (FITC)-labeled recombinant protein expressed in the HEK293 cells with a N terminal His-tag.

HY-P78560

	CD70 Protein, Human (Biotinylated, HEK293, His-Avi&Flag) CD70; CD27LG; TNFSF7; TNFSF7G; CD27L	Human	HEK293
	As a ligand of CD27, CD70 protein is an indispensable part of T cell immune coordination and is of particular importance in antiviral responses. The CD70-CD27 pathway emerged as a key player that contributes to the generation and maintenance of T cell-mediated immune responses. CD70 Protein, Human (Biotinylated, HEK293, His-Avi&Flag) is the recombinant human-derived CD70 protein, expressed by HEK293 , with N-Avi, N-Flag, N-His labeled tag.

HY-P701287

	*FITC-Labeled CD70* Trimer Protein, Human (HEK293, His-Flag)** CD70; CD27LG; TNFSF7; TNFSF7G; CD27L	Human	HEK293
	As a ligand of CD27, CD70 protein is an indispensable part of T cell immune coordination and is of particular importance in antiviral responses. The CD70-CD27 pathway emerged as a key player that contributes to the generation and maintenance of T cell-mediated immune responses. FITC-Labeled CD70 Trimer Protein, Human (HEK293, His-Flag) is the recombinant human-derived FITC-Labeled CD70 Trimer protein, expressed by HEK293 , with His labeled tag.

HY-P72741AF

	*Animal-Free CD70* Protein, Mouse (His)** soluble CD27 Ligand; sCD27 Ligand; TNFSF7; CD70; Tnfs; Tnlg8a	Mouse	E. coli
	The CD70 protein is an important member of the tumor necrosis factor family and plays a crucial role in immune regulation and cellular responses.Its study enhances our understanding of immune regulation, providing potential applications for immunoassays and therapeutics.Animal-Free CD70 Protein, Mouse (His) is the recombinant mouse-derived animal-FreeCD70 protein, expressed by E.coli , with N-His, N-His labeled tag.This product is for cell culture use only.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Host:	Mouse (1) Rabbit (1)
Reactivity:	Human (2)
Application:	FC (2) ELISA (2)
Isotype:	IgG (1)
Conjugation:	Non-conjugated (2) Biotin (3)
Clonality:	Monoclonal (2) Recombinant (1)
Modification:	Unmodified (2)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P85005

	CD70 Antibody (YA4697) CD70; CD27L; CD27LG; TNFSF7; CD70 antigen; CD27 ligand; CD27-L; Tumor necrosis factor ligand superfamily member 7; CD antigen CD70; CD70 nanobody;	ELISA, FC	Human
	CD70 Antibody (YA4697) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CD70.

HY-P81664

	CD70 Antibody (YA1409) CD70; CD27LG; TNFSF7; TNFSF7G; CD27L	FC, ELISA	Human
	CD70 Antibody (YA1409) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CD70.